Core Viewpoint - The news discusses ongoing legal actions regarding investor claims against companies Yingfeituo (002528) and Xiangrikui (300111) due to alleged violations of information disclosure laws, with both cases currently in various stages of litigation [1][2][3][4][5]. Group 1: Yingfeituo (002528) - The law firm represented by attorney Xu Feng has submitted a new case for investor claims against Yingfeituo to the Shenzhen Intermediate People's Court on February 3, 2026 [1][4]. - A previous ruling in favor of investors has been made, with Yingfeituo appealing the decision, which has now entered the second trial phase [1][4]. - The company received a notice from the China Securities Regulatory Commission (CSRC) on January 24, 2025, regarding an investigation into alleged information disclosure violations [4]. Group 2: Xiangrikui (300111) - On February 3, 2026, attorney Xu Feng also submitted a new case for investor claims against Xiangrikui to the Shaoxing Intermediate People's Court, which is awaiting further court arrangements [2][4]. - The company received a notice from the CSRC on January 14, 2026, regarding an investigation into misleading statements related to its restructuring proposal [3][5]. - Investors who purchased Xiangrikui shares between September 22, 2025, and December 26, 2025, and sold or held them after December 26, 2025, are eligible to file claims [5].

Core Viewpoint - ST Lingnan and ST Huaxi are facing delisting risks due to performance indicators hitting red lines, leading to the imposition of "*ST" status [1][3] Group 1: Financial Performance and Risks - ST Lingnan has triggered two delisting red lines as per Shenzhen Stock Exchange rules: negative profit totals and net assets, with a total loss exceeding 3.6 billion yuan over three years [3] - ST Huaxi is expected to have negative net assets by the end of 2025, which also triggers delisting risk warnings [3] - Both companies have previously faced other risk warnings due to ongoing issues [3] Group 2: Regulatory and Compliance Issues - ST Lingnan has been under investigation for information disclosure violations since September 2025, with prior warnings about inflated revenue and inadequate provisions [5] - ST Huaxi faced scrutiny in April 2025 for a significant revision of its earnings forecast, changing from profit to loss [5] Group 3: Investor Actions and Legal Recourse - Investors affected by the companies' performance can pursue legal claims, with specific timeframes outlined for ST Lingnan and ST Huaxi [7] - Legal actions are being prepared by law firms on behalf of investors who suffered losses during specified periods [7]

Core Viewpoint - The announcement from Zhejiang Sunflower Health Technology Co., Ltd. (stock code: 300111) regarding a formal investigation by the China Securities Regulatory Commission (CSRC) due to misleading statements and violations of information disclosure has triggered a significant compensation claim process affecting 130,000 shareholders [1][2]. Group 1: Company Background and Events - On September 22, 2025, Sunflower announced a restructuring plan to acquire 100% of Xipu Materials and 40% of Beid Pharmaceutical, aiming to enter the semiconductor materials sector, which led to a surge in stock price and an increase in shareholder numbers from 60,000 to 130,000 within three months [1]. - A deep investigation by Zhitong Finance on December 25, 2025, revealed that Xipu Materials' core production capacity was fabricated, with the factories not operational and lacking necessary permits, contradicting the restructuring proposal [2]. - Following the investigation, the Shenzhen Stock Exchange issued a notice requiring Sunflower to verify the authenticity of its production capacity and related transactions, but the company failed to provide satisfactory responses, leading to the CSRC's formal investigation and the termination of the restructuring plan on January 14, 2026 [2]. Group 2: Market Reaction and Financial Impact - The stock price of Sunflower plummeted following the investigation, with a 10% drop on December 26, 2025, and an additional 10% decline after the announcement of the investigation, culminating in a 20% limit down on January 15, 2026, resulting in significant losses for investors [2]. - As of February 2, 2026, the stock price was reported at 4.39 yuan, a substantial decrease from the peak value during the restructuring hype, indicating severe financial repercussions for investors [2]. Group 3: Compensation Process - Investors who purchased Sunflower shares between September 22, 2025, and December 25, 2025, and held them through the latter date are eligible to file for compensation without upfront legal fees, as per the provisions of the Securities Law of the People's Republic of China [3]. - A call to action for affected shareholders to gather trading records and other necessary documentation to pursue claims through legal channels has been emphasized, with guidance available from legal professionals [3].

Core Viewpoint - The Xinjiang Securities Regulatory Bureau has conducted an investigation into Ba Yi Steel for violations of information disclosure laws, resulting in penalties for the company's chairman, Ke Shanliang [1][5]. Group 1: Violations and Transactions - Ba Yi Steel engaged in non-operational fund transactions with its controlling shareholder, Ba Yi Steel Group, totaling approximately 3.68 billion yuan in 2022, 2.81 billion yuan in 2023, and 2.51 billion yuan in 2024 for funds received [2]. - The company also transferred approximately 3.64 billion yuan to Ba Yi Steel Group in 2022, 2.77 billion yuan in 2023, and 2.53 billion yuan in 2024 [2]. Group 2: Disclosure Obligations - Ba Yi Steel failed to disclose the non-operational fund transactions in its annual reports for 2022, 2023, and 2024, constituting a significant omission as per the Securities Law [3]. - The company is required to disclose such transactions in accordance with the Securities Law and related regulations, which it did not comply with [3]. Group 3: Accountability and Penalties - Ke Shanliang, as the chairman, is held responsible for the company's failure to fulfill its disclosure obligations and has been warned and fined 1 million yuan [4][5]. - The penalty must be paid within 15 days of receiving the decision, and there are provisions for administrative review or litigation if the decision is contested [6].

Core Viewpoint - Hubei Meirya Co., Ltd. (ST Meirya) has been penalized by the China Securities Regulatory Commission (CSRC) for failing to disclose non-operating fund occupation and related party transactions, which involved significant amounts of money flowing to its actual controller, Zheng Jiping [2][3]. Summary by Sections Administrative Penalty - On January 31, 2026, ST Meirya announced that it and related personnel received an administrative penalty decision [1]. - The CSRC found that ST Meirya and its actual controller Zheng Jiping were involved in illegal activities related to undisclosed related party transactions [2]. Financial Transactions - From November 2022 to March 2023, ST Meirya and its subsidiaries transferred a total of 10.372 million yuan to related parties, which constituted non-operating fund occupation [2]. - The amounts involved were 7.15 million yuan (9.42% of the latest audited net assets) in late 2022 and 3.222 million yuan (5.12% of the latest audited net assets) in the first half of 2023 [2]. Disclosure Issues - ST Meirya failed to disclose the non-operating fund occupation in its 2022 annual report and 2023 semi-annual report, with undisclosed amounts of 7.15 million yuan and 3.222 million yuan respectively [2][3]. - The company corrected accounting errors in April 2024, indicating inaccuracies in financial data disclosures [3]. Legal Implications - Due to the violations, ST Meirya may face civil compensation claims from investors who suffered losses as a result of the company's actions [4]. - Investors who purchased ST Meirya's securities between April 29, 2023, and April 29, 2024, and sold or held them after April 30, 2024, are eligible to register for compensation [4].

Core Viewpoint - Hubei Meirya Co., Ltd. (ST Meirya) has been penalized by the China Securities Regulatory Commission (CSRC) for failing to disclose non-operating fund occupation and related party transactions, leading to potential legal actions from affected investors [1][4][10]. Group 1: Regulatory Findings - The CSRC found that ST Meirya and its actual controller, Zheng Jiping, were involved in non-operating fund occupation amounting to 103.72 million yuan, which was used for Zheng and his affiliates' daily operations or debt repayment [2][8]. - From November 2022 to March 2023, ST Meirya failed to disclose related party transactions totaling 71.5 million yuan and 32.22 million yuan, which represented 9.42% and 5.12% of the company's latest audited net assets, respectively [2][8]. - The company did not follow the required procedures for disclosing related party transactions, including those with its indirect controlling shareholder, Beijing Zhongfang Silk Road Investment Management Co., Ltd., which involved a transaction of 5.4 million yuan in 2022 [3][9]. Group 2: Financial Reporting Issues - ST Meirya's 2022 annual report contained inaccurate financial data, necessitating a correction announcement in April 2024 [3][9]. - The company has since recovered 105.92 million yuan related to the non-operating fund occupation, with 102.22 million yuan disclosed in its 2023 annual report [2][8]. Group 3: Investor Compensation - Affected investors who purchased ST Meirya's securities between April 29, 2023, and April 29, 2024, may register for compensation claims [10][5]. - Legal representatives are collecting claims from investors who suffered losses due to the company's violations, emphasizing the importance of the administrative penalty as a prerequisite for civil lawsuits [10][11].

Core Viewpoint - Jiangsu Baoxin Technology Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may lead to civil compensation claims from affected investors [1][4]. Group 1: Company Announcement - On January 31, 2026, Baoxin Technology announced that it received a notice of investigation from the CSRC due to alleged violations by the company and its actual controller, Mr. Ma Wei [1][4]. - The CSRC's decision to investigate is based on the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][4]. Group 2: Investor Compensation - Affected investors who purchased Baoxin Technology's stocks or bonds before January 31, 2026, and sold or continued to hold them after this date may register for compensation claims [2][5]. - The compensation scope includes investment differences, commissions, and stamp duties, as per the Civil Code and relevant judicial interpretations [1][4]. Group 3: Legal Process and Requirements - The process of civil compensation claims is not affected by whether the company is delisted, but entering bankruptcy may significantly impact the litigation process [3][6]. - Investors must provide specific documentation for compensation registration, including a copy of their ID, securities account confirmation, and transaction records [3][6].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、监管出手立案调查 2026年1月30日，宝馨科技（维权）发布公告，因涉嫌信息披露违法违规，中国证监会决定对公司及实 际控制人马伟立案。此次立案调查可能与公司过去的控股股东与关联方的非经营性资金占用情况有关。 根据宝馨科技在2024年4月30日披露的关于自查非经营性资金占用情况及整改报告，2022年9月至2023年 10月，公司控股股东及关联方累计发生非经营性占用公司资金8800万元。 截至2023年10月31日，上述资金占用已全部收回，并以资金占用金额、资金占用天数按6%的年化利率 计算利息，于2024年4月收取全部利息154.45万元。公司已完成对该事项的深查与整改，而此次被立案 调查涉及对该事项的追溯处罚。 二、投资者索赔要求 上海沪紫刘鹏律师表示信息披露违法违规的背后，往往隐藏着不法关联交易、违规资金占用、财务造假 等严重违法行为。依据相关法 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、退市警报拉响 2026年1月31日，ST岭南（维权）发布《2025年年度业绩预告》，ST岭南的财务指标同时触及了《深圳 证券交易所股票上市规则》第9.3.1条中的两项退市红线：最近一个会计年度的利润总额、净利润和扣非 净利润三者孰低为负值，且扣除后的营业收入低于3亿元；同时，期末净资产也为负值。 根据《深圳证券交易所股票上市规则》相关规定，公司股票交易可能在披露《2025年年度报告》后被实 施退市风险警示，股票简称前将冠以"*ST"字样。 ST岭南的情况尤为复杂。该公司此前已连续三年亏损，累计亏损超过36亿元。2024年，其内部控制审 计报告被年审会计师事务所出具了否定意见。 随后在2025年9月，公司及原控股股东收到中国证券监督管理委员会出具的《立案告知书》，因涉嫌信 息披露违法违规，中国证监会已正式决定对公司及原控股股东立案。 二、立案或早有端 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、信披违规被立案 荃银高科（维权）1月30日晚发布公告称，公司收到中国证监会下发的《立案告知书》，因涉嫌信息披 露违法违规，根据相关法律法规，证监会决定对公司立案。 公告强调，目前公司各项生产经营活动均正常开展，立案调查不会对公司的正常生产经营活动产生重大 影响。 在立案调查和会计调整的双重背景下，荃银高科的业绩前景并不乐观。 公司预计2025年归属于上市公司股东的净利润亏损1.8亿元至2.7亿元，而上年同期为盈利9712.96万元。 这意味着荃银高科年度业绩将出现公司上市后首次亏损。 今日开盘，其股价大幅下跌。不少投资者无端遭受损失。根据历史案例，上市公司一旦被证监会立案调 查，最终被认定为信息披露违法违规并受到处罚的可能性较大。 二、会计差错或是缘由 在立案公告披露的同一日，荃银高科还披露了公司召开第五届董事会第三十一次会议并审议通过了《关 于前 ...